These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7542239)

  • 21. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
    J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.
    Dezube BJ
    Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.
    Barillari G; Sgadari C; Fiorelli V; Samaniego F; Colombini S; Manzari V; Modesti A; Nair BC; Cafaro A; Stürzl M; Ensoli B
    Blood; 1999 Jul; 94(2):663-72. PubMed ID: 10397733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
    J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.
    Ensoli B; Buonaguro L; Barillari G; Fiorelli V; Gendelman R; Morgan RA; Wingfield P; Gallo RC
    J Virol; 1993 Jan; 67(1):277-87. PubMed ID: 8416373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.
    Toschi E; Barillari G; Sgadari C; Bacigalupo I; Cereseto A; Carlei D; Palladino C; Zietz C; Leone P; Stürzl M; Buttò S; Cafaro A; Monini P; Ensoli B
    Mol Biol Cell; 2001 Oct; 12(10):2934-46. PubMed ID: 11598182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
    Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
    AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells.
    Cantaluppi V; Biancone L; Boccellino M; Doublier S; Benelli R; Carlone S; Albini A; Camussi G
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):965-76. PubMed ID: 11461682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
    Barillari G; Gendelman R; Gallo RC; Ensoli B
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7941-5. PubMed ID: 7690138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.
    Barillari G; Ensoli B
    Clin Microbiol Rev; 2002 Apr; 15(2):310-26. PubMed ID: 11932235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery of human fibroblast growth factor-1 gene to brain by modified rat brain endothelial cells.
    Johnston P; Nam M; Hossain MA; Indurti RR; Mankowski JL; Wilson MA; Laterra J
    J Neurochem; 1996 Oct; 67(4):1643-52. PubMed ID: 8858949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of AIDS-associated Kaposi's sarcoma.
    Ensoli B; Barillari G; Gallo RC
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):281-95. PubMed ID: 2022594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
    Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B
    J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
    Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
    J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
    Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
    Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of HIV-1 Tat in the pathogenesis of AIDS-associated Kaposi's sarcoma.
    Buonaguro L; Buonaguro FM; Tornesello ML; Beth-Giraldo E; Del Gaudio E; Ensoli B; Giraldo G
    Antibiot Chemother (1971); 1994; 46():62-72. PubMed ID: 7826041
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.
    Chang HC; Samaniego F; Nair BC; Buonaguro L; Ensoli B
    AIDS; 1997 Oct; 11(12):1421-31. PubMed ID: 9342064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.
    Wu Z; Cavallaro U; Marchisio PC; Soria MR; Maier JA
    Am J Pathol; 1998 Jun; 152(6):1599-605. PubMed ID: 9626063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
    Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.